Suppr超能文献

6-氨磺酰基糖精作为碳酸酐酶抑制剂的X射线晶体学和动力学研究。

X-ray crystallographic and kinetic investigations of 6-sulfamoyl-saccharin as a carbonic anhydrase inhibitor.

作者信息

Alterio V, Tanc M, Ivanova J, Zalubovskis R, Vozny I, Monti S M, Di Fiore A, De Simone G, Supuran C T

机构信息

Istituto di Biostrutture e Bioimmagini-CNR, via Mezzocannone 16, 80134 Naples, Italy.

出版信息

Org Biomol Chem. 2015 Apr 7;13(13):4064-9. doi: 10.1039/c4ob02648a.

Abstract

6-Sulfamoyl-saccharin was investigated as an inhibitor of 11 α-carbonic anhydrase (CA, EC 4.2.1.1) isoforms of human (h) origin, hCA I-XIV, and X-ray crystallographic data were obtained for its adduct with hCA II, the physiologically dominant isoform. This compound possesses two potential zinc-binding groups, the primary sulfamoyl one and the secondary, acylatedsulfonamide. Saccharin itself binds to the Zn(II) ion from the CA active site coordinating with this last group, in deprotonated (SO2N(-)CO) form. Here we explain why 6-sulfamoyl-saccharin, unlike saccharin, binds to the metal ion from the hCA II active site by its primary sulfonamide moiety and not the secondary one as saccharin itself. Our study is useful for shedding new light to the structure-based drug design of isoform-selective CA inhibitors of the sulfonamide type.

摘要

对6-氨磺酰基糖精作为人源(h)11种α-碳酸酐酶(CA,EC 4.2.1.1)同工型hCA I-XIV的抑制剂进行了研究,并获得了其与生理上占主导地位的同工型hCA II加合物的X射线晶体学数据。该化合物具有两个潜在的锌结合基团,主要的氨磺酰基和次要的酰化磺酰胺。糖精本身以去质子化(SO2N(-)CO)形式从CA活性位点与最后一个基团配位结合到Zn(II)离子上。在这里,我们解释了为什么6-氨磺酰基糖精与糖精不同,它通过其主要的磺酰胺部分而非次要部分从hCA II活性位点结合到金属离子上。我们的研究有助于为磺酰胺类型的同工型选择性CA抑制剂的基于结构的药物设计提供新的思路。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验